Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China

被引:0
作者
Li He
Jun-Dong Li
Ying Xiong
Xin Huang
Long Huang
Jia-xin Lin
Yun Zhou
Min Zheng
机构
[1] Sun Yat-sen University Cancer Center,Department of Gynecology, State Key Laboratory of Oncology in Southern China
来源
Archives of Gynecology and Obstetrics | 2014年 / 289卷
关键词
Endometrial stromal sarcoma; Pelvic lymphadenectomy; CD10; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:383 / 391
页数:8
相关论文
共 89 条
[1]  
Echt G(1990)Treatment of uterine sarcomas Cancer 66 35-39
[2]  
Jepson J(2000)Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 88 1425-1431
[3]  
Steel J(2003)Endometrial stromal sarcoma of the uterus: analysis of 25 patients Eur J Obstet Gynecol Reprod Biol 109 209-213
[4]  
Pautier P(2007)A multiinstitutional review of outcomes of endometrial stromal sarcoma Gynecol Oncol 105 630-634
[5]  
Genestie C(1989)Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 (“enkephalinase”): direct evidence by cDNA transfection analysis Proc Natl Acad Sci USA 86 297-301
[6]  
Rey A(1997)CD10. A review Appl Immunohistochem 5 125-140
[7]  
Haberal A(2001)Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases Mod Pathol 14 465-471
[8]  
Kayikcioglu F(2001)CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms Histopathology 39 273-278
[9]  
Boran N(2002)CD10 is a marker for normal and neoplastic endometrial stromal cells Int J Gynecol Pathol 21 41-47
[10]  
Caliskan E(1999)Endometrial stromal sarcoma: a clinicopathologic study Eur J Gynaecol Oncol 20 33-34